Methadone, a drug prescribed for managing the symptoms of heroin withdrawal and chronic pain, has been linked to the formation of the carcinogenic compound N-Nitrosodimethylamine (NDMA) in drinking water. Understanding which compounds contribute to NDMA formation in water could lead to tailored wastewater treatment approaches to remove the risk of contamination.
Photo Credit: LEONELLO CALVETTI/Getty Images
Methadone, a drug prescribed for managing the symptoms of heroin withdrawal and chronic pain, has been linked to the formation of the carcinogenic compound N-Nitrosodimethylamine (NDMA) in drinking water.1 Understanding which compounds contribute to NDMA formation in water could lead to tailored wastewater treatment approaches to remove the risk of contamination.
NDMA is a carcinogenic compound that can contaminate drinking water, and is thought to enter drinking water in recycled wastewater that has been disinfected using chloramination. Lead author David Hanigan told The Column: “Previously people thought that natural organic matter in the water was responsible but that has slowly been disproven, as we typically see no correlation between organic carbon (representative of natural organic matter) in the water and NDMA formation in disinfected waters.”
Wastewater is a very complex sample, making it difficult to identify factors important to NDMA formation. Research has previously suggested that candidate compounds can react to form NDMA when chloramines are added, but this approach does not show if the precursors are actually in the surface water or the wastewater. With funding from the Water Research Foundation, researchers from Arizona State University (Arizona, USA), the University of Colorado at Boulder (Colorado, USA), and the University of Toronto (Ontario, Canada) collaborated to screen surface waters and the secondary effluent of a wastewater treatment plant from across the United States and Canada.
Samples of wastewater and secondary efluent were screened using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (LC–QTOF-MS), looking for candidate compounds with tertiary amine groups. Methadone was identified as a potential candidate and was quantified using gas chromatography coupled to mass spectrometry (GC–MS). Methadone was detected in samples at concentrations ranging from 32–2256 ng/mL.
A methadone standard was then used in a NDMA formation assay to determine the rate of formation. Hanigan said: “The novelty is that methadone forms a lot of NDMA, 6 of 10 molecules are reacted, and that we have already inherently shown occurrence by the original discovery. Thereby, we can account for its contribution and estimate the risk.”
So what is next? Hanigan told The Column that the team will continue to investigate NDMA formation to find other candidate compounds that could be contributing factors. He said: “We are sure there are others out there as we are not yet able to account for the total NDMA formation, and if we are able to determine which are the most important, we can begin to propose tailored treatment technologies.” - B.D.
Reference
1. D. Hanigan et al, Environmental Science & Technology Letters DOI: 10.1021/acs.estlett.5b00096 (2015).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.